Lv3
238 积分 2024-08-21 加入
Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
1个月前
已完结
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes
1个月前
已完结
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology
1个月前
已完结
Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress
2个月前
已完结
Prevalence of subclinical hypothyroidism and longitudinal thyroid stimulating hormone changes in youth with metabolic dysfunction-associated steatotic liver disease: an observational study
3个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
3个月前
已关闭
Carrier-free nanodrug targeting glucose metabolism for enhanced rheumatoid arthritis treatment
3个月前
已完结
Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis
7个月前
已完结
Selective Agonists of Thyroid Hormone Receptor Beta for the Treatment of NASH
8个月前
已完结
TRIB3–TRIM8 complex drives NAFLD progression by regulating HNF4α stability
9个月前
已完结
皖公网安备34019202002308
